SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-22-000087
Filing Date
2022-07-26
Accepted
2022-07-26 06:36:58
Documents
14
Period of Report
2022-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20220726.htm   iXBRL 8-K 50580
2 EX-99.1 isee2qearningspressrelease.htm EX-99.1 66931
6 image_0.jpg GRAPHIC 14302
  Complete submission text file 0001410939-22-000087.txt   289061

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20220726.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20220726_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20220726_pre.xml EX-101.PRE 12525
8 EXTRACTED XBRL INSTANCE DOCUMENT isee-20220726_htm.xml XML 10555
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 221104847
SIC: 2834 Pharmaceutical Preparations